Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Tositumomab> ?p ?o. }
Showing items 1 to 69 of
69
with 100 items per page.
- Tositumomab abstract "Tositumomab is a drug for the treatment of follicular lymphoma. It is an IgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cells.Tositumomab is applied in a sequential infusion followed by iodine (131I) tositumomab, which is the same antibody covalently bound to the radionuclide iodine-131 (131I). 131I emits both beta and gamma radiation and decays with a half-life of 8 days.Clinical trials have established the efficacy of the tositumomab/iodine (131I) tositumomab regimen in patients with relapsed or chemotherapy/rituxan refractory follicular lymphoma.This drug combination is manufactured by Corixa (now GlaxoSmithKline). It sells in the U.S. under the trade name Bexxar. Sale of the drug will be discontinued in February 2014 due to the decline in usage (fewer than 75 patients in 2012) and the existence of other similar drugs.Bexxar was developed by Mark Kaminski and Richard Wahl.[citation needed]There is some evidence that it may cause a smaller decrease in platelet counts than ibritumomab tiuxetan does.".
- Tositumomab atcPrefix "V10".
- Tositumomab atcSuffix "XA53".
- Tositumomab atcSupplemental "(sequential regimen with 131I form)".
- Tositumomab casNumber "192391-48-3".
- Tositumomab drugbank "DB00081".
- Tositumomab fdaUniiCode "0343IGH41U".
- Tositumomab wikiPageExternalLink dictionary?CdrID=367411.
- Tositumomab wikiPageID "6609238".
- Tositumomab wikiPageRevisionID "600112778".
- Tositumomab atcPrefix "V10".
- Tositumomab atcSuffix "XA53".
- Tositumomab c "6416".
- Tositumomab casNumber "192391".
- Tositumomab chembl "1201604".
- Tositumomab chemspiderid "NA".
- Tositumomab date "August 2013".
- Tositumomab drugbank "DB00081".
- Tositumomab h "9874".
- Tositumomab hasPhotoCollection Tositumomab.
- Tositumomab kegg "D08622".
- Tositumomab mabType "mab".
- Tositumomab medlineplus "a609013".
- Tositumomab molecularWeight "143859.7".
- Tositumomab n "1688".
- Tositumomab o "1987".
- Tositumomab reason "drug discovery and development are universally the work of large, diverse teams".
- Tositumomab s "44".
- Tositumomab source "o".
- Tositumomab target CD20.
- Tositumomab tradename "Bexxar".
- Tositumomab type "mab".
- Tositumomab unii "343".
- Tositumomab verifiedfields "changed".
- Tositumomab verifiedrevid "470611959".
- Tositumomab subject Category:Monoclonal_antibodies.
- Tositumomab type Abstraction100002137.
- Tositumomab type Antibody115027189.
- Tositumomab type Chemical114806838.
- Tositumomab type Compound114818238.
- Tositumomab type Macromolecule114944888.
- Tositumomab type Material114580897.
- Tositumomab type Matter100020827.
- Tositumomab type Molecule114682133.
- Tositumomab type MonoclonalAntibodies.
- Tositumomab type MonoclonalAntibody115029781.
- Tositumomab type OrganicCompound114727670.
- Tositumomab type Part113809207.
- Tositumomab type PhysicalEntity100001930.
- Tositumomab type Protein114728724.
- Tositumomab type Relation100031921.
- Tositumomab type Substance100019613.
- Tositumomab type Thing100002452.
- Tositumomab type Unit109465459.
- Tositumomab type Drug.
- Tositumomab type DrugProduct.
- Tositumomab type FunctionalSubstance.
- Tositumomab comment "Tositumomab is a drug for the treatment of follicular lymphoma. It is an IgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cells.Tositumomab is applied in a sequential infusion followed by iodine (131I) tositumomab, which is the same antibody covalently bound to the radionuclide iodine-131 (131I).".
- Tositumomab label "Tositumomab".
- Tositumomab label "Tositumomab".
- Tositumomab sameAs Tositumomab.
- Tositumomab sameAs m.0gdn51.
- Tositumomab sameAs Q3995913.
- Tositumomab sameAs Q3995913.
- Tositumomab sameAs tositumomab.
- Tositumomab sameAs DB00081.
- Tositumomab sameAs Tositumomab.
- Tositumomab wasDerivedFrom Tositumomab?oldid=600112778.
- Tositumomab isPrimaryTopicOf Tositumomab.